<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04287881</url>
  </required_header>
  <id_info>
    <org_study_id>İstanbulMUZEYNEP2</org_study_id>
    <nct_id>NCT04287881</nct_id>
  </id_info>
  <brief_title>Methylenetetrahydrofolate Reductase Deficiency in Ischemic Stroke</brief_title>
  <official_title>Investigation the Incidence of Methylenetetrahydrofolate Reductase Deficiency in Ischemic Cerebrovascular Diseases Presenting With Epileptic Seizures in Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Istanbul Medeniyet University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Istanbul Medeniyet University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Adult onset epileptic seizures is rare and often associated with metabolic disorders, drugs&#xD;
      and intracranial pathologies such as ischemia, hemorrhage or space-occupying lesions.&#xD;
      Methylenetetrahydrofolate reductase (MTHFR) deficiency is one of the reasons that cause&#xD;
      epileptic seizures in adults and can be ignored. MTHFR deficiency is an autosomal recessive&#xD;
      disorder that results in hyperhomocysteinemia and causes a predisposition to venous and&#xD;
      arterial thrombosis. The incidence of the polymorphism is around 40% in some countries. The&#xD;
      aim of the retrospective study is to investigate the incidence of MTHFR deficiency in&#xD;
      patients with adult-onset epileptic seizures.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Epileptic seizures that begin in adulthood seriously affect patients, their relatives and the&#xD;
      society in which they live financially and psychologically. The etiology of epileptic&#xD;
      seizures starting at adult age includes head trauma, central nervous system infections,&#xD;
      intracranial lesions, cerebrovascular events, metabolic diseases and drugs. While the causes&#xD;
      of childhood epileptic seizures are generally considered idiopathic, adult-onset epileptic&#xD;
      seizures are almost always due to a pathological process. Epileptic seizures in adults may be&#xD;
      a symptom of ischemic stroke. MTHFR deficiency is associated with raised homocysteine&#xD;
      concentration in the body and increased risk of stroke (1). Studies have demonstrated that&#xD;
      hyperhomocysteinemia is an independent risk factor for stroke (2).&#xD;
&#xD;
      MTHFR is the key enzyme in remethylation of homocysteine to methionine. MTHFR deficiency is&#xD;
      an autosomal-recessive disease characterized by high homocysteine and low or normal&#xD;
      methionine. MTHFR deficiency can cause vascular thrombosis in adults at early age; increased&#xD;
      osteoporosis in elderly people; deep vein thrombosis, abortus during pregnancy; and&#xD;
      infertility in adult males. In children, it is associated with intrauterine growth&#xD;
      retardation, congenital heart diseases, neural tube defects, chromosome anomalies and&#xD;
      hematologic tumors. In any age group, it might cause convulsions, increased thrombosis risk&#xD;
      with some anticonvulsants and with the use of nitrogen protoxide in surgeries, and neuromotor&#xD;
      retardation (3).&#xD;
&#xD;
      The aim of this retrospective study is to investigate the incidence of MTHFR deficiency in&#xD;
      patients presenting with adult-onset epileptic seizures and diagnosed as ischemic&#xD;
      cerebrovascular disease as a result of diagnostic tests.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 31, 2019</start_date>
  <completion_date type="Actual">February 20, 2020</completion_date>
  <primary_completion_date type="Actual">February 15, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Methylenetetrahydrofolate reductase (MTHFR) deficiency</measure>
    <time_frame>Up to 6 weeks</time_frame>
    <description>The incidence of methylenetetrahydrofolate reductase (MTHFR) deficiency in ischemic stroke</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">32</enrollment>
  <condition>Hyperhomocysteinemia, Thrombotic, Cbs-Related</condition>
  <condition>Ischemic Stroke</condition>
  <condition>Epilepsy</condition>
  <arm_group>
    <arm_group_label>Adult patients who have epileptic seizures</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patients with adult-onset epileptic seizures and diagnosed ischemic stroke.</description>
  </arm_group>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>Methylenetetrahydrofolate reductase (MTHFR) deficiency</intervention_name>
    <description>To investigate the incidence of MTHFR deficiency in patients with adult-onset epileptic seizures and diagnosed ischemic stroke</description>
    <arm_group_label>Adult patients who have epileptic seizures</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  The patients with adult-onset epileptic seizures and diagnosed ischemic stroke in 3&#xD;
             years period.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pediatric patients with epileptic seizures&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>ZEYNEP ORHON, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Istanbul Medeniyet University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Zeynep Orhon</name>
      <address>
        <city>İstanbul</city>
        <zip>34722</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Istanbul MU Goztepe Training and Research Hospital</name>
      <address>
        <city>Istanbul</city>
        <zip>34730</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>February 22, 2020</study_first_submitted>
  <study_first_submitted_qc>February 25, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 27, 2020</study_first_posted>
  <last_update_submitted>February 25, 2020</last_update_submitted>
  <last_update_submitted_qc>February 25, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Istanbul Medeniyet University</investigator_affiliation>
    <investigator_full_name>Zeynep Nur Orhon</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Methylenetetrahydrofolate reductase (MTHFR) deficiency</keyword>
  <keyword>Ischemic Stroke</keyword>
  <keyword>Epileptic seizures</keyword>
  <keyword>Adult patients</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Ischemic Stroke</mesh_term>
    <mesh_term>Hyperhomocysteinemia</mesh_term>
    <mesh_term>Ischemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

